Hepatitis B Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have a hepatitis B virus (HBV) infection, whether it is untreated or being treated with a certain type of antiviral medication
- People who are willing and able to sign a written consent form agreeing to take part
- People who are covered by a social security scheme
- Healthy volunteers aged between 18 and 80 who are willing and able to sign a written consent form agreeing to take part
Who may not be able to join:
- People who also have a hepatitis C (HCV), HIV, or hepatitis D (HDV) infection — and for healthy volunteers, this also includes having hepatitis B (HBV)
- People who had an episode of acute (sudden onset) hepatitis in the year before joining the trial
- People with other liver-related conditions, such as those linked to heavy alcohol use, obesity (body mass index over 30), diabetes, or a combination of high cholesterol/fats and known high blood pressure
- People with an underlying immune system disorder or a cancer diagnosis
- People whose condition prevents them from fully understanding what taking part in the trial involves
- People who are under court protection, legal guardianship, or a similar legal arrangement
- Women who are pregnant or breastfeeding
- Healthy volunteers whose vaccination records do not match what would be expected based on their blood test results (confirm with trial site)
- Anyone whose blood pregnancy test comes back positive at the time of joining
- Patients who test positive for HCV, HIV, or HDV at the time of joining
- Healthy volunteers who test positive for HBV, HCV, HIV, or HDV at the time of joining
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Paul CARRIER, MD, University Hospital, Limoges
Phone: +335 55 05 80 22
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
RNA sequencing of B cells from CHB patients at different stages, description of their molecular signature
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.